Cargando…

Secukinumab treatment of Parry-Romberg syndrome

Detalles Bibliográficos
Autores principales: Sideris, Emily, de Zwaan, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516175/
https://www.ncbi.nlm.nih.gov/pubmed/32995450
http://dx.doi.org/10.1016/j.jdcr.2020.07.036
_version_ 1783586949991235584
author Sideris, Emily
de Zwaan, Sally
author_facet Sideris, Emily
de Zwaan, Sally
author_sort Sideris, Emily
collection PubMed
description
format Online
Article
Text
id pubmed-7516175
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75161752020-09-28 Secukinumab treatment of Parry-Romberg syndrome Sideris, Emily de Zwaan, Sally JAAD Case Rep Case Report Elsevier 2020-07-27 /pmc/articles/PMC7516175/ /pubmed/32995450 http://dx.doi.org/10.1016/j.jdcr.2020.07.036 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Sideris, Emily
de Zwaan, Sally
Secukinumab treatment of Parry-Romberg syndrome
title Secukinumab treatment of Parry-Romberg syndrome
title_full Secukinumab treatment of Parry-Romberg syndrome
title_fullStr Secukinumab treatment of Parry-Romberg syndrome
title_full_unstemmed Secukinumab treatment of Parry-Romberg syndrome
title_short Secukinumab treatment of Parry-Romberg syndrome
title_sort secukinumab treatment of parry-romberg syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516175/
https://www.ncbi.nlm.nih.gov/pubmed/32995450
http://dx.doi.org/10.1016/j.jdcr.2020.07.036
work_keys_str_mv AT siderisemily secukinumabtreatmentofparryrombergsyndrome
AT dezwaansally secukinumabtreatmentofparryrombergsyndrome